Evidence map›Paper›PMID 37253934›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2023

Low Molecular Weight Heparin-Aspirin-Prednisolone Combination Does Not Increase the Live Birth Rate in Recurrent Implantation Failure: A Retrospective Cohort Study.

Kiper Aslan, Isil Kasapoglu, Ceren Cinar, Cihan Cakir, Berrin Avci, Gurkan Uncu

Abstract read
PubMed Publisher
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Immunosuppressants in women with repeated implantation failure in assisted reproductive techniques: a systematic review and meta-analysis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kiper AslanFaculty of Medicine, Department of Obstetrics and Gynecology, Bursa Uludag University, Bursa, Turkey.ORCID 0000-0002-9277-7735
Isil KasapogluFaculty of Medicine, Department of Obstetrics and Gynecology, Bursa Uludag University, Bursa, Turkey.ORCID 0000-0002-1953-2475
Ceren CinarFaculty of Medicine, Department of Obstetrics and Gynecology, Bursa Uludag University, Bursa, Turkey.ORCID 0000-0001-5202-6235
Cihan CakirFaculty of Medicine, Department of Histology and Embryology, Bursa Uludag University, Bursa, Turkey.ORCID 0000-0002-8332-7353
Berrin AvciFaculty of Medicine, Department of Histology and Embryology, Bursa Uludag University, Bursa, Turkey.ORCID 0000-0001-8135-5468
Gurkan UncuFaculty of Medicine, Department of Obstetrics and Gynecology, Bursa Uludag University, Bursa, Turkey. guncu@gurkanuncu.org.ORCID 0000-0001-7660-8344
Bursa Uludağ Üni̇versi̇tesi̇ · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the triple combination of adjuvants (low molecular weight heparin (LMWH)-aspirin-prednisolone) whether it improves the live birth rates of IVF&ICSI patients with previous implantation failure. This retrospective study included 1095 patients with >2 failed either fresh or frozen single embryo transfer cycles between 2014 Jan and 2021 Jan. Patients were divided into two subgroups. Group A consisted of patients with only vaginal progesterone for luteal phase support. Group B consisted of patients with triple (daily subcutaneous LMWH, daily 150 mg aspirin, and daily 16 mg prednisolone) luteal phase supplementation to vaginal progesterone. Demographic parameters, cycle characteristics, embryology, and pregnancy outcomes were compared, and the study's primary outcome was the live birth rate. Demographic parameters were similar between the groups. Positive b-hCG, miscarriage, and live birth rates were similar between groups as Group A vs. Group B, positive b-hCG 30.8% (190/617) vs. 35.4% (169/478), miscarriage rates 4.4% (27/617) vs. 6.7% (32/478), and live birth rates 20.4% (126/617) vs. 23.8% (114/478), respectively. When patients were stratified according to previous failures, live birth rates were still similar. Pregnancy outcomes were significantly improved in only patients with diminished ovarian reserve (Group A vs. Group B, positive b-hCG 24.2% vs. 34.3%, live birth rate 12.1% vs. 21.9%, p < 0.01). Whether the embryo transfer was fresh or frozen-thawed did not affect the results. A combined supplementation of LMWH, aspirin, and prednisolone in the luteal phase does not improve live birth rates of IVF&ICSI patients with previous implantation failure except potentially for patients with diminished ovarian reserve.

Indexed as

Abortion, SpontaneousProgesteroneAspirinBirth RateFemaleFertilization in VitroHeparin, Low-Molecular-WeightHumansLive BirthPrednisolonePregnancyPregnancy RateRetrospective StudiesAspirinHeparin, Low-Molecular-WeightPrednisoloneProgesteroneAspirinDiminished ovarian reserveImplantation failureInfertilityLow molecular weight heparinPrednisolone

Identifiers

PMID37253934
OpenAlexW4378783675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.